Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 343 of 1,261
  1. US 11008622

    Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof

    Wellmarker Bio Co., LTD. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  2. US 11007147

    Hydrogel toxin-absorbing or binding nanoparticles

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted
  3. US 11008337

    Chiral diaryl macrocycles as modulators of protein kinases

    TURNING POINT THERAPEUTICS, INC. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  4. US 11008589

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted
  5. US 11008548

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Precision BioSciences, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  6. US 11008382

    Antibodies to oxidized phospholipids

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted
  7. US 11008551

    Method to increase the infectivity of virus particles

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 18, 2021 · Expires May 13, 2041

    granted
  8. US 11008372

    Targeting proteins for degradation

    The Board of Regents of the University of Texas System · Granted May 18, 2021 · Expires May 13, 2041

    granted
  9. US 11008553

    Halogenation of complex organic compounds

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 18, 2021 · Expires May 13, 2041

    granted
  10. US 11008378

    Compositions and methods for immunomodulation in an organism

    UNIVERSITY OF CONNECTICUT · Granted May 18, 2021 · Expires May 13, 2041

    granted
  11. US 11008360

    Indoleacetic acid derivative and preparation method and pharmaceutical use thereof

    Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences · Granted May 18, 2021 · Expires May 13, 2041

    granted
  12. US 11008325

    Inhibitors of cancer invasion, attachment, and/or metastasis

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted May 18, 2021 · Expires May 13, 2041

    granted
  13. US 11008305

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 18, 2021 · Expires May 13, 2041

    granted
  14. US 11008309

    Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

    Karyopharm Therapeutics Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  15. US 11008334

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted
  16. US 11007281

    Nano/micromotors for active and dynamic intracellular payload delivery

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted
  17. US 11007265

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  18. US 11007270

    Polymer-semaxanib moiety conjugates

    Nektar Therapeutics · Granted May 18, 2021 · Expires May 13, 2041

    granted
  19. US 11007263

    Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

    The United States of America, as represented by the Secretary of Agriculture · Granted May 18, 2021 · Expires May 13, 2041

    granted
  20. US 11008289

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted May 18, 2021 · Expires May 13, 2041

    granted
  21. US 11007255

    Cancer vaccines and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  22. US 11007226

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  23. US 11007254

    Compositions and methods for treating central nervous system injury

    United States Government as represented by the Department of Veterans Affairs · Granted May 18, 2021 · Expires May 13, 2041

    granted
  24. US 11007248

    Suppression of allergic lung inflammation and hyperreactivity

    The Regents of the University of California · Granted May 18, 2021 · Expires May 13, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.